Mode
Text Size
Log in / Sign up
N/A Completed N=200 Randomized Double-blind Health Services Research

Home-based Diabetes-Modified Behavioral Activation Treatment for Low Income Seniors With T2DM

Source: ClinicalTrials.gov NCT04203147 ↗
Enrolled (actual)
200
Serious AEs
0.0%
Results posted
Feb 2026
Primary outcomePrimary: Glycemic Control (HbA1c) — 8.8; 9.0 mean percentage of HbA1c

Summary

The objective of this protocol is to evaluate the efficacy and cost-effectiveness of 8 sessions of in-home, telephone-delivered, culturally-modified, manualized diabetes-modified, behavioral activation treatment (Home DM-BAT) delivered by trained diabetes nurse educators among low income, ethnic minority seniors with poorly controlled T2DM. The aims of this randomized controlled efficacy trial are: Aim: To test the efficacy of Home DM-BAT on glycemic control (hemoglobin A1c). Hypothesis: Low income, minority seniors with poorly controlled T2DM randomized to Home DM-BAT will have significantly greater improvements in glycemic control (hemoglobin A1c) at 12 months of follow-up compared to the control group (in-home, telephone-delivered supportive therapy - ST).

Outcome Measures

OutcomeResultp-value
PRIMARY
Glycemic Control (HbA1c)
8.8; 9.0

Eligibility Criteria

Inclusion Criteria

  • Age >=65 years of age;
  • Self-identified as Black/African American or Hispanic;
  • Clinical diagnosis of T2DM verified by an HbA1c >=8% at the screening assessment;
  • Able to communicate in English or Spanish; and
  • Resident of independent, subsidized, assisted senior housing facility or community dwelling elderly adults in the greater Milwaukee area and surrounding counties that have high African American/Hispanic populations.

Exclusion Criteria

  • Mental confusion at screening assessment suggesting significant dementia;
  • Participation in other diabetes research;
  • Alcohol or drug abuse/dependency;
  • Active psychosis or acute mental disorder; and
  • Life expectancy <12 months at screening assessment.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04203147). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search